Results 11 to 20 of about 235,538 (306)

Advances in Platelet Counting [PDF]

open access: yesHematology, 2001
Accurate and reliable platelet counting is critical for the clinical management of platelet disorders, especially in thrombocytopenia. The platelet count is used to determine if the patient requires a platelet transfusion. As the prophylactic transfusion trigger is now set anywhere between 10-20 × 10(9)/L (depending upon the institution) it is ...
Samuel J. Machin   +2 more
openaire   +2 more sources

Association between platelets and in-hospital mortality in critically ill patients with tumours: a retrospective cohort study

open access: yesBMJ Open, 2022
Objectives Platelet count is an independent predictor of mortality in patients with cancer. It remains unknown whether the platelet count is related to in-hospital mortality in severely ill patients with tumours.Design A retrospective study based on a ...
Yue Chen   +12 more
doaj   +1 more source

Platelet Counts during Pregnancy [PDF]

open access: yesNew England Journal of Medicine, 2018
(N Engl J Med. 2018;379:32–43) In the present study, the authors evaluated platelet counts in women (15 to 44 y of age) who delivered at the Oklahoma University Medical Center between 2011 and 2014. Their objectives were to (1) evaluate the potential severity of gestational thrombocytopenia (<150,000 platelets/mm3 at the time of delivery ...
Jennifer D. Peck   +7 more
openaire   +8 more sources

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll   +3 more
doaj   +1 more source

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. [PDF]

open access: yesPLoS ONE, 2018
This prospective observational study was designed to analyze platelet functions across time in 50 patients scheduled for liver transplantation (LT) secondary to decompensated cirrhosis or hepatocellular carcinoma.
Daniel Eyraud   +15 more
doaj   +1 more source

Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome

open access: yesPlatelets, 2021
Little is known about evolution of platelet count after treatment with direct-acting antiviral agents (DAAs). The study aimed to evaluate the changes in platelet count after treatment with DAAs among thrombocytopenic patients with HCV-related advanced ...
Zeinab Soliman   +9 more
doaj   +1 more source

Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma

open access: yesCurrent Oncology, 2022
The prognostic role of platelet count in hepatocellular carcinoma (HCC) remains unclear, and in fact both thrombocytopenia and thrombocytosis are reported as predictors of unfavourable outcomes.
Christopher Schrecker   +7 more
doaj   +1 more source

Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients

open access: yesInternational Journal of Hypertension, 2020
Background. Platelet consumption followed by homocysteine-induced endothelial injury suggests a crosstalk between platelet activation and homocysteine on hypertension.
Jianan Zhang   +8 more
doaj   +1 more source

Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia [PDF]

open access: yesPeerJ, 2017
Background Pretreatment platelet count has been reported as a potential tool to predict survival outcome in several solid tumors. However, the predictive value of pretreatment platelet count remains obscure in de novo acute myeloid leukemia (AML ...
Qianying Zhang   +6 more
doaj   +2 more sources

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

open access: yesBMC Gastroenterology, 2020
Background Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count  50,000/µL at baseline: the proportions of patients who did not require platelet transfusion were 84–96%, which might be overestimated.
Hiroaki Nomoto   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy